Skip to main content
Premium Trial:

Request an Annual Quote

New Products: NanoInk's NanoArray Assay System

Premium

NanoInk this week launched its NanoArray Assay System for the automated analysis of its protein NanoArray assays.

According to the Skokie, Ill.-based firm, the system enables the detection, identification, and quantitation of clinically relevant, low abundance proteins from a wide variety of sample types for applications such as biomarker analysis, translational medicine, and toxicology.

The desktop unit can create reproducible protein arrays over millimeter areas and then can fluorescently image these arrays with 0.5 nanometer resolution, according to the firm.

The company also claims that the platform can achieve sub-picogram sensitivities with 2 nanoliters or less of sample.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more